MedTrace Logo

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

NCT00282035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2135

Last updated 2018-07-13

No results posted yet for this study

Summary

To determine if Accelerated Partial Breast Irradiation, using 3D CRT, is as effective as Whole Breast Irradiation following breast conserving surgery in women with an new histological diagnosis of ductal carcinoma in situ only or invasive breast cancer without evidence of metastatic disease. Effectiveness will be determined by the rate of ipsilateral breast tumour recurrence.

General objective is to improve the convenience and quality of life of female patients who receive breast irradiation.

Conditions

Interventions

RADIATION

APBI utilizing 3D-CRT radiation

Accelerated partial breast irradiation utilizing 3D-CRT

RADIATION

Whole breast irradiation

Whole breast irradiation

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Canadian Breast Cancer Research Alliance

    collaborator OTHER

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Tim Whelan, MD · Ontario Clinical Oncology Group / Juravinski Cancer Centre

  • Ivo Olivotto, MD · British Columbia Cancer Agency - Vancouver Island Centre

  • Mark Levine, MD · Ontario Clinical Oncology Group (OCOG)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Australia
  • Canada
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282035 on ClinicalTrials.gov